OTLK
OTLK
US69012T3059
Outlook Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.413.535 --
--
Cost of Revenue 1.356.330 --
--
Gross Profit 57.205 --
--
67.118.871 71.703.235
6.4%
Operating Income -67.061.666 -71.703.235
6.5%
Pretax Income -63.976.692 -75.363.914
15.1%
Net Income Common Stockholders -62.424.863 -75.366.714
17.2%
-- --
--
-- --
--
ende